Screener
Amylyx Pharmaceuticals, Inc. AMLX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s current ratio?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported current ratio of 12.1× in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s current ratio changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s current ratio increased by 38.9% year-over-year, from 8.7× to 12.1×.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s current ratio?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s current ratio has grown at a 24.0% compound annual growth rate (CAGR), from 6× to 14.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude